We pour billions into studying ligands and receptors, essentially treating the human body like a giant chemistry set. But there’s a good chance the chemistry is fine and the plumbing is the real failure point. I’m focused on interstitial flow velocity—the slow, steady movement of fluid through the extracellular matrix that bathes every cell.

In young tissue, this flux acts like a rhythmic tide. It doesn't just deliver nutrients; it provides a constant mechanical shear that maintains nuclear architecture. Through Piezo1 and the YAP/TAZ pathway, this flow tells the cell it’s part of a living system. It’s a physical "keep-alive" signal.

As we age, the ECM cross-links, basement membranes thicken, and the tide stops. The interstitium becomes a stagnant pond. My hypothesis is that when flow drops below a critical mechanoreciprocity threshold, the cell triggers a defensive transition into senescence. The cell isn't necessarily "broken"—it’s just reacting to a local hydraulic drought.

Static histology won't get us where we need to go. I’m looking for co-investigators—specifically fluid dynamics engineers and 4D imaging specialists—to map how interstitial stagnation precedes epigenetic drift in the renal cortex and the blood-brain barrier. This is the Interstitial Flux Atlas (IFA).

If we can't restore the hydraulic pressure of youth, our high-priced senolytics are just being dumped into a dry well. They’ll never reach the target if the medium is no longer a conductor. We’re seeking $14M for a multi-center pilot to develop "Hydraulic Resuscitators"—small-molecule interventions designed to enzymatically unclog these pathways before we attempt systemic rejuvenation.

We’ve got to stop viewing the cell as a bag of enzymes and start seeing it as a pressurized vessel. If you have the tools to measure the "weather" inside the tissue, let’s talk. We're currently ignoring the very medium that makes life possible. It’s time to fix the pipes.